JPWO2021182573A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021182573A5 JPWO2021182573A5 JP2021532006A JP2021532006A JPWO2021182573A5 JP WO2021182573 A5 JPWO2021182573 A5 JP WO2021182573A5 JP 2021532006 A JP2021532006 A JP 2021532006A JP 2021532006 A JP2021532006 A JP 2021532006A JP WO2021182573 A5 JPWO2021182573 A5 JP WO2021182573A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- chain variable
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025053695A JP2025092589A (ja) | 2020-03-12 | 2025-03-27 | 癌の治療及び／又は予防のための医薬品 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020043021 | 2020-03-12 | ||
| JP2020043021 | 2020-03-12 | ||
| PCT/JP2021/009798 WO2021182573A1 (ja) | 2020-03-12 | 2021-03-11 | 癌の治療及び／又は予防のための医薬品 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025053695A Division JP2025092589A (ja) | 2020-03-12 | 2025-03-27 | 癌の治療及び／又は予防のための医薬品 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2021182573A1 JPWO2021182573A1 (https=) | 2021-09-16 |
| JPWO2021182573A5 true JPWO2021182573A5 (https=) | 2024-02-28 |
| JP7797875B2 JP7797875B2 (ja) | 2026-01-14 |
Family
ID=77671643
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021532006A Active JP7797875B2 (ja) | 2020-03-12 | 2021-03-11 | 癌の治療及び／又は予防のための医薬品 |
| JP2025053695A Pending JP2025092589A (ja) | 2020-03-12 | 2025-03-27 | 癌の治療及び／又は予防のための医薬品 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025053695A Pending JP2025092589A (ja) | 2020-03-12 | 2025-03-27 | 癌の治療及び／又は予防のための医薬品 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230129035A1 (https=) |
| EP (1) | EP4119156A4 (https=) |
| JP (2) | JP7797875B2 (https=) |
| KR (1) | KR20220152318A (https=) |
| BR (1) | BR112022018157A2 (https=) |
| CA (1) | CA3175137A1 (https=) |
| WO (1) | WO2021182573A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0911926A2 (pt) * | 2008-08-05 | 2020-08-18 | Toray Industries, Inc | composições farmacêuticas, anticorpos e usos de um anticorpo ou um fragmento do mesmo. |
| CN117693363A (zh) * | 2021-07-27 | 2024-03-12 | 东丽株式会社 | 用于癌的治疗和/或预防的药品 |
| WO2023008461A1 (ja) * | 2021-07-27 | 2023-02-02 | 東レ株式会社 | 癌の治療及び／又は予防のための医薬品 |
| KR20240041917A (ko) * | 2021-07-27 | 2024-04-01 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방을 위한 의약품 |
| WO2024043257A1 (ja) * | 2022-08-24 | 2024-02-29 | 東レ株式会社 | 癌の治療及び／又は予防のための医薬品 |
| JPWO2024043258A1 (https=) * | 2022-08-24 | 2024-02-29 | ||
| AU2023329558A1 (en) * | 2022-08-24 | 2025-02-27 | Toray Industries, Inc. | Medicament for treatment and/or prevention of cancer |
| WO2024190815A1 (ja) * | 2023-03-14 | 2024-09-19 | 第一三共株式会社 | 抗ｃｄｈ６抗体－薬物コンジュゲートとｖｅｇｆ阻害剤の組み合わせ |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| DE69535243T2 (de) | 1994-07-13 | 2007-05-10 | Chugai Seiyaku K.K. | Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper |
| DK1069185T3 (da) | 1998-04-03 | 2011-06-27 | Chugai Pharmaceutical Co Ltd | Humaniseret antistof mod human vævsfaktor (TF) og fremgangsmåde til at konstruere humaniseret antistof |
| DK1071700T3 (da) | 1998-04-20 | 2010-06-07 | Glycart Biotechnology Ag | Glykosylerings-modifikation af antistoffer til forbedring af antistofafhængig cellulær cytotoksicitet |
| US6737056B1 (en) | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| CA2704600C (en) | 1999-04-09 | 2016-10-25 | Kyowa Kirin Co., Ltd. | A method for producing antibodies with increased adcc activity |
| FR2807767B1 (fr) | 2000-04-12 | 2005-01-14 | Lab Francais Du Fractionnement | Anticorps monoclonaux anti-d |
| CA2512729C (en) | 2003-01-09 | 2014-09-16 | Macrogenics, Inc. | Identification and engineering of antibodies with variant fc regions and methods of using same |
| US8388955B2 (en) | 2003-03-03 | 2013-03-05 | Xencor, Inc. | Fc variants |
| DE10359795A1 (de) | 2003-12-19 | 2005-07-21 | Bayer Technology Services Gmbh | Strangverdampfervorrichtung |
| BRPI0911926A2 (pt) | 2008-08-05 | 2020-08-18 | Toray Industries, Inc | composições farmacêuticas, anticorpos e usos de um anticorpo ou um fragmento do mesmo. |
| EP2711018A1 (en) | 2009-06-22 | 2014-03-26 | MedImmune, LLC | Engineered Fc regions for site-specific conjugation |
| EP2480671B8 (en) | 2009-09-22 | 2015-10-28 | ProBioGen AG | Process for producing molecules containing specialized glycan structures |
| HUE040012T2 (hu) | 2010-02-04 | 2019-02-28 | Toray Industries | Gyógyászati ágens rák kezelésére és/vagy megelõzésére |
| DK2532366T3 (da) | 2010-02-04 | 2017-01-02 | Toray Industries | Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer |
| DK2532680T3 (da) | 2010-02-04 | 2015-07-20 | Toray Industries | Medicinsk sammensætning til behandling og/eller forebyggelse af cancer |
| CA2788545C (en) | 2010-02-04 | 2019-03-26 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
| US9115200B2 (en) * | 2010-02-04 | 2015-08-25 | Toray Industries, Inc. | Pharmaceutical composition for treating cancer using a monoclonal antibody having immunological reactivity with CAPRIN-1 |
| RU2603742C2 (ru) | 2010-02-04 | 2016-11-27 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики рака |
| JP2013528357A (ja) | 2010-03-29 | 2013-07-11 | ザイムワークス，インコーポレイテッド | 強化又は抑制されたエフェクター機能を有する抗体 |
| PL2740793T3 (pl) | 2011-08-04 | 2018-04-30 | Toray Industries, Inc. | Kompozycja leku do leczenia i/lub zapobiegania nowotworowi |
| US9181348B2 (en) | 2011-08-04 | 2015-11-10 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| PT2740489T (pt) | 2011-08-04 | 2017-01-10 | Toray Industries | Composição farmacêutica para o tratamento e/ou a prevenção do cancro pancreático |
| PT2740796T (pt) | 2011-08-04 | 2017-07-26 | Toray Industries | Composição farmacêutica para o tratamento e/ou profilaxia de cancro |
| RU2595400C2 (ru) | 2011-08-04 | 2016-08-27 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики злокачественной опухоли |
| EP2740794B1 (en) | 2011-08-04 | 2018-04-04 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| WO2013125654A1 (ja) | 2012-02-21 | 2013-08-29 | 東レ株式会社 | 癌の治療及び／又は予防用医薬組成物 |
| ES2739612T3 (es) | 2012-02-21 | 2020-02-03 | Toray Industries | Composición farmacéutica para el tratamiento de cáncer |
| US9260513B2 (en) * | 2012-02-21 | 2016-02-16 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of cancer |
| BR112014021103A2 (pt) | 2012-02-21 | 2019-10-15 | Toray Industries, Inc | Anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo |
| WO2013147176A1 (ja) | 2012-03-30 | 2013-10-03 | 東レ株式会社 | 胆嚢癌の治療及び／又は予防用医薬組成物 |
| JP6107654B2 (ja) | 2012-03-30 | 2017-04-05 | 東レ株式会社 | 肝臓癌の治療及び／又は予防用医薬組成物 |
| CN112587671A (zh) | 2012-07-18 | 2021-04-02 | 博笛生物科技有限公司 | 癌症的靶向免疫治疗 |
| AU2014303375B2 (en) | 2013-08-09 | 2019-07-04 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of cancer |
| CA3061874A1 (en) * | 2017-06-22 | 2018-12-27 | Novartis Ag | Il-1beta binding antibodies for use in treating cancer |
| AU2019242520B2 (en) * | 2018-03-30 | 2026-02-26 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of cancer |
| JP7103097B2 (ja) | 2018-09-13 | 2022-07-20 | トヨタ自動車株式会社 | 燃料電池車両 |
-
2021
- 2021-03-11 CA CA3175137A patent/CA3175137A1/en active Pending
- 2021-03-11 JP JP2021532006A patent/JP7797875B2/ja active Active
- 2021-03-11 KR KR1020227035364A patent/KR20220152318A/ko active Pending
- 2021-03-11 BR BR112022018157A patent/BR112022018157A2/pt unknown
- 2021-03-11 WO PCT/JP2021/009798 patent/WO2021182573A1/ja not_active Ceased
- 2021-03-11 US US17/910,538 patent/US20230129035A1/en active Pending
- 2021-03-11 EP EP21767020.7A patent/EP4119156A4/en active Pending
-
2025
- 2025-03-27 JP JP2025053695A patent/JP2025092589A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2021182573A5 (https=) | ||
| AU2019242520B2 (en) | Pharmaceutical composition for treatment and/or prevention of cancer | |
| JP7797875B2 (ja) | 癌の治療及び／又は予防のための医薬品 | |
| CN119789868A (zh) | 用于癌的治疗和/或预防的药品 | |
| US20250228937A1 (en) | Medicament for treatment and/or prevention of cancer | |
| JPWO2021182574A5 (https=) | ||
| JP7715041B2 (ja) | 癌の治療及び／又は予防のための医薬品 | |
| JPWO2021182571A5 (https=) | ||
| JP7793986B2 (ja) | 癌の治療及び／又は予防のための医薬品 | |
| JPWO2021182570A5 (https=) | ||
| US20230159635A1 (en) | Medicament for treatment and/or prevention of cancer | |
| JPWO2021182572A5 (https=) | ||
| JP7793985B2 (ja) | 癌の治療及び／又は予防のための医薬品 | |
| US20240325529A1 (en) | Medicament for treatment and/or prevention of cancer | |
| EP4578458A1 (en) | Medicament for treatment and/or prevention of cancer | |
| EP4578459A1 (en) | Pharmaceutical product for treatment and/or prevention of cancer | |
| EP4640235A1 (en) | Medicament for treatment and/or prevention of cancer | |
| CN119768182A (zh) | 用于癌的治疗和/或预防的药品 |